Moreover, the addition of the specific COX-2 inhibitor celecoxib has been shown to abrogate the marked increase of PGE2 levels observed in non small cell lung cancer patients after carboplatin/paclitaxel administration [36]. The gene discussed is PTGS2; the disease is non-small cell lung carcinoma.